Clinical Trial Update: PK/PD Relationship of CAZ/AVI and FOS in the Treatment of Patients With Infections Due to CRE

View source ↗

Summary

Clinical trial exploring the PK/PD relationship of ceftazidime-avibactam and fosfomycin for infections caused by carbapenem-resistant Enterobacterales (CRE); th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carbapenem-resistant Enterobacterales Infection

Drugs mentioned

• Monurol (fosfomycin trometamol)
• Zerbaxa (ceftolozane-tazobactam)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Gram Negative Infections, Antimicrobial Resistance (AMR) | Status: RECRUITING